DocStore

The Premier Marketplace to Buy and Sell Professional Documents

DocStore Search:
Per Page: 152550
  • Grünenthal GmbH – Product Pipeline Review – 2012
    Grünenthal GmbH – Product Pipeline Review – 2012

    $500.00

    $500.00

    From:GlobalMarketsDirect

    Document Overview:
    The report provides data on the Grünenthal GmbH’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Grünenthal GmbH’s corporate website, SEC filings, investor presentations and featured press releases, both from Grünenthal GmbH and industry-specific third party sources, put together by Global Markets Direct’s team.
    View Document
  • Angelini Group – Product Pipeline Review – 2012
    Angelini Group – Product Pipeline Review – 2012

    $500.00

    $500.00

    From:GlobalMarketsDirect

    Document Overview:
    The report provides data on the Angelini Group’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Angelini Group’s corporate website, SEC filings, investor presentations and featured press releases, both from Angelini Group and industry-specific third party sources, put together by Global Markets Direct’s team.
    View Document
  • ViroPharma Incorporated – Product Pipeline Review – 2012
    ViroPharma Incorporated – Product Pipeline Review – 2012

    $500.00

    $500.00

    From:GlobalMarketsDirect

    Document Overview:
    The report provides data on the ViroPharma Incorporated’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ViroPharma Incorporated’s corporate website, SEC filings, investor presentations and featured press releases, both from ViroPharma Incorporated and industry-specific third party sources, put together by Global Markets Direct’s team.
    View Document
  • Advaxis, Inc. – Product Pipeline Review – 2012
    Advaxis, Inc. – Product Pipeline Review – 2012

    $500.00

    $500.00

    From:GlobalMarketsDirect

    Document Overview:
    The report provides data on the Advaxis, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Advaxis, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Advaxis, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
    View Document
  • CytRx Corporation – Product Pipeline Review – 2012
    CytRx Corporation – Product Pipeline Review – 2012

    $500.00

    $500.00

    From:GlobalMarketsDirect

    Document Overview:
    The report provides data on the CytRx Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, CytRx Corporation’s corporate website, SEC filings, investor presentations and featured press releases, both from CytRx Corporation and industry-specific third party sources, put together by Global Markets Direct’s team.
    View Document
  • XOMA Corporation – Product Pipeline Review – 2012
    XOMA Corporation – Product Pipeline Review – 2012

    $500.00

    $500.00

    From:GlobalMarketsDirect

    Document Overview:
    The report provides data on the XOMA Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, XOMA Corporation’s corporate website, SEC filings, investor presentations and featured press releases, both from XOMA Corporation and industry-specific third party sources, put together by Global Markets Direct’s team.
    View Document
  • Valeant Pharmaceuticals International, Inc. – Product Pipeline Review – 2012
    Valeant Pharmaceuticals International, Inc. – Product Pipeline Review – 2012

    $500.00

    $500.00

    From:GlobalMarketsDirect

    Document Overview:
    The report provides data on the Valeant Pharmaceuticals International, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Valeant Pharmaceuticals International, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Valeant Pharmaceuticals International, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
    View Document
  • UCB S.A. – Product Pipeline Review – 2012
    UCB S.A. – Product Pipeline Review – 2012

    $500.00

    $500.00

    From:GlobalMarketsDirect

    Document Overview:
    The report provides data on the UCB S.A.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, UCB S.A.’s corporate website, SEC filings, investor presentations and featured press releases, both from UCB S.A. and industry-specific third party sources, put together by Global Markets Direct’s team.
    View Document
  • Shire Plc – Product Pipeline Review – 2012
    Shire Plc – Product Pipeline Review – 2012

    $500.00

    $500.00

    From:GlobalMarketsDirect

    Document Overview:
    The report provides data on the Shire Plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Shire Plc’s corporate website, SEC filings, investor presentations and featured press releases, both from Shire Plc and industry-specific third party sources, put together by Global Markets Direct’s team.
    View Document
  • Synta Pharmaceuticals Corp. – Product Pipeline Review – 2012
    Synta Pharmaceuticals Corp. – Product Pipeline Review – 2012

    $500.00

    $500.00

    From:GlobalMarketsDirect

    Document Overview:
    The report provides data on the Synta Pharmaceuticals Corp.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Synta Pharmaceuticals Corp.’s corporate website, SEC filings, investor presentations and featured press releases, both from Synta Pharmaceuticals Corp. and industry-specific third party sources, put together by Global Markets Direct’s team.
    View Document
  • POZEN Inc. – Product Pipeline Review – 2012
    POZEN Inc. – Product Pipeline Review – 2012

    $500.00

    $500.00

    From:GlobalMarketsDirect

    Document Overview:
    The report provides data on the POZEN Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, POZEN Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from POZEN Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
    View Document
  • QLT Inc. – Product Pipeline Review – 2012
    QLT Inc. – Product Pipeline Review – 2012

    $500.00

    $500.00

    From:GlobalMarketsDirect

    Document Overview:
    The report provides data on the QLT Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, QLT Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from QLT Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
    View Document
  • Paladin Labs Inc. – Product Pipeline Review – 2012
    Paladin Labs Inc. – Product Pipeline Review – 2012

    $500.00

    $500.00

    From:GlobalMarketsDirect

    Document Overview:
    The report provides data on the Paladin Labs Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Paladin Labs Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Paladin Labs Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
    View Document
  • Pharmos Corporation – Product Pipeline Review – 2012
    Pharmos Corporation – Product Pipeline Review – 2012

    $500.00

    $500.00

    From:GlobalMarketsDirect

    Document Overview:
    The report provides data on the Pharmos Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Pharmos Corporation’s corporate website, SEC filings, investor presentations and featured press releases, both from Pharmos Corporation and industry-specific third party sources, put together by Global Markets Direct’s team.
    View Document
  • NewLink Genetics Corporation – Product Pipeline Review – 2012
    NewLink Genetics Corporation – Product Pipeline Review – 2012

    $500.00

    $500.00

    From:GlobalMarketsDirect

    Document Overview:
    The report provides data on the NewLink Genetics Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, NewLink Genetics Corporation’s corporate website, SEC filings, investor presentations and featured press releases, both from NewLink Genetics Corporation and industry-specific third party sources, put together by Global Markets Direct’s team.
    View Document
Per Page: 152550